Brief Summary

This study aims to measure levels of mental illness stigma based on successful treatment and societal role fulfillment of the individual portrayed with mental illness.

Trial Health

On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment

400

participants targeted

Target at P75+ for not_applicable

Timeline

Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach

1 country

1 active site

Status

completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

2 months study duration

First Submitted

Initial submission to the registry

June 7, 2024

Completed

8 days until next milestone

Study Start

First participant enrolled

June 15, 2024

Completed

1 month until next milestone

First Posted

Study publicly available on registry

July 19, 2024

Completed

27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2024

Completed

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2024

Completed

Last Updated

January 28, 2025

Status Verified

January 1, 2025

Enrollment Period

2 months

First QC Date

June 7, 2024

Last Update Submit

January 27, 2025

Conditions

Mental Illness

Outcome Measures

Primary Outcomes (3)

Personal Acceptance Scale (PAS)
The PAS is a questionnaire targeted to public stigma, the "negative attitudes, beliefs, and behaviors held within a community" against individuals with mental illness. Each yes adds one point to the scale, and five questions from each scale were reverse-scored to match the direction of the scale. There were ten questions, therefore it generated a score between zero and ten. Higher scores indicated more acceptance and less stigma towards mental illness, while lower scores indicated less acceptance and more stigma towards mental illness.
One year. For each interview, approximately 60 minutes.
Broad Acceptance Scale (BAS)
The BAS is a questionnaire targeted to distal public stigma. Each yes adds one point to the scale, and five questions from each scale were reverse-scored to match the direction of the scale. There were ten questions, therefore it generated a score between zero and ten. Higher scores indicated more acceptance and less stigma towards mental illness, while lower scores indicated less acceptance and more stigma towards mental illness.
One year. For each interview, approximately 60 minutes.
Attributed Stigma Scale
Attributed stigma scale will be a modification of the PAS to gather understanding of what participants believe the attitudes of others in their community are. Each yes adds one point to the scale, and five questions from each scale were reverse-scored to match the direction of the scale. There were ten questions, therefore it generated a score between zero and ten. Higher scores indicated more acceptance and less stigma towards mental illness, while lower scores indicated less acceptance and more stigma towards mental illness.
One year. For each interview, approximately 60 minutes.

Study Arms (8)

Major Depressive Disorder without treatment or role fulfillment

EXPERIMENTAL

Other: Major Depressive Disorder without treatment or role fulfillment

Major Depressive Disorder with treatment but no role fulfillment

EXPERIMENTAL

Other: Major Depressive Disorder with treatment but no role fulfillment

Major Depressive Disorder without treatment but with role fulfillment

EXPERIMENTAL

Other: Major Depressive Disorder without treatment but with role fulfillment

Major Depressive Disorder with treatment and role fulfillment

EXPERIMENTAL

Other: Major Depressive Disorder with treatment and role fulfillment

Schizophrenia without treatment or role fulfillment

EXPERIMENTAL

Other: Schizophrenia without treatment or role fulfillment

Schizophrenia with treatment but no role fulfillment

EXPERIMENTAL

Other: Schizophrenia with treatment but no role fulfillment

Schizophrenia without treatment but with role fulfillment

EXPERIMENTAL

Other: Schizophrenia without treatment but with role fulfillment

Schizophrenia with treatment and role fulfillment

EXPERIMENTAL

Other: Schizophrenia with treatment and role fulfillment